icon A Detailed Guide to Cannabinoid Hyperemesis Syndrome - The Cannabis Company


  • Login

A Detailed Guide to Cannabinoid Hyperemesis Syndrome


Cannabinoid Hyperemesis Syndrome, or CHS, is a relatively recent medical discovery gaining increasing attention within the healthcare community and beyond. This condition is characterised by recurrent bouts of severe nausea, vomiting, and abdominal pain and is uniquely associated with chronic cannabis use.


CHS is a paradoxical syndrome associated with chronic cannabis use. Cyclical episodes of debilitating nausea and vomiting characterise it. People suffering from CHS often find that hot showers alleviate their symptoms, a distinguishing feature of this syndrome. Despite cannabis's well-known anti-emetic properties, in large amounts and with chronic use, it appears to have the opposite effect, leading to the severe symptoms seen in CHS.


Brief Overview


The syndrome is believed to be caused by the buildup of cannabinoids in the body due to long-term cannabis use. It's a condition that's still not fully understood, and it's often misdiagnosed due to its similarity with other conditions causing nausea and vomiting.


CHS is becoming more prevalent with the increasing legalisation and use of cannabis worldwide. Both healthcare professionals and the public must be aware of this condition, its symptoms, and its connection to cannabis use. This awareness can lead to quicker diagnosis, effective treatment, and better prognoses for those affected.


Please note that while cannabis use is a risk factor for CHS, not everyone who uses cannabis will develop this condition. It's a complex syndrome involving multiple factors, including individual genetic susceptibility.


Symptoms of CHS


Cannabinoid Hyperemesis Syndrome (CHS) is a condition that presents with a unique set of symptoms, which can be categorised into early and late stages. Understanding these symptoms is crucial for early detection and effectively managing the condition.


Early Symptoms


Individuals with CHS may experience subtle and often overlooked symptoms in the early stages. These can include morning sickness, a fear of vomiting (emetophobia), and abdominal discomfort. Some people may also experience a decrease in appetite and weight loss.


One unique early symptom of CHS is the increased use of hot showers or baths. Individuals with CHS often find that hot showers provide temporary relief from their symptoms, although the reason for this is not fully understood.


Late Symptoms


As the condition progresses, the symptoms of CHS become more severe. The hallmark of this stage is recurrent episodes of severe nausea and vomiting that can last for hours or even days. These episodes often have a cyclical pattern, with periods of symptom-free intervals in between.


Abdominal pain becomes more pronounced later, often described as a continuous, severe ache. Dehydration due to excessive vomiting is another common late symptom, which can lead to complications such as kidney failure if not treated promptly.


Differences from Other Conditions


 Differences From Other Conditions


CHS can be challenging to diagnose because its symptoms closely resemble those of other conditions, such as cyclic vomiting syndrome (CVS) and gastroparesis. However, there are key differences.


The most distinguishing feature of CHS is its association with chronic cannabis use and the alleviation of symptoms with hot showers or baths. These features are not typically seen in other conditions.


Furthermore, while other conditions may respond to anti-nausea medications, CHS often does not. This resistance to treatment, combined with a history of chronic cannabis use, can be a strong indicator of CHS.


Understanding these symptoms and differences is crucial for healthcare professionals to accurately diagnose and provide effective treatment for those suffering from this debilitating condition.


Causes and Risk Factors


The exact cause of Cannabinoid Hyperemesis Syndrome (CHS) is not fully understood, but it is closely associated with chronic cannabis use. There are also other potential risk factors that may contribute to the development of this condition.


Connection with Cannabis Use


It is believed that the accumulation of cannabinoids, the active compounds in cannabis, in the body over time can lead to the development of CHS.


Cannabinoids interact with the endocannabinoid system in our bodies, which regulates various physiological processes, including pain sensation, mood, and appetite. While cannabis is often used for its anti-nausea and pain-relieving effects, paradoxically, chronic use can lead to severe nausea, vomiting, and pain seen in CHS.


Notably, the risk of developing CHS increases with the frequency and duration of cannabis use. However, not everyone who uses cannabis chronically will develop CHS, suggesting that other factors may also be at play.


Other Potential Risk Factors


While chronic cannabis use is the primary risk factor, research suggests that there may be other contributing factors. Some studies indicate a potential genetic predisposition to CHS, implying that some individuals may be more susceptible to developing the condition due to their genetic makeup.


Additionally, the type of cannabis used may also play a role. For instance, cannabis with higher concentrations of the cannabinoid THC may increase the risk of CHS.


Furthermore, some individuals with CHS have been found to have a history of psychiatric conditions, such as anxiety and depression, or other substance use disorders, suggesting a potential link.


In conclusion, while the connection between cannabis use and CHS is clear, more research is needed to understand the other potential risk factors fully. This will help develop effective prevention strategies and treatments for this debilitating condition.


Diagnosis of CHS


Diagnosis of CHS


Diagnosing Cannabinoid Hyperemesis Syndrome (CHS) can be complex due to its similarity with other conditions. However, understanding the diagnostic criteria, differential diagnosis, and diagnostic procedures can aid in the accurate identification of this condition.


Diagnostic Criteria


The diagnosis of CHS is primarily clinical, based on a set of criteria. These include long-term cannabis use, recurrent episodes of severe nausea and vomiting, relief of symptoms with hot baths or showers, and the absence of other causes that could explain these symptoms.


It's important to note that the cessation of cannabis use leading to symptom resolution is a crucial diagnostic criterion. However, this can only be confirmed retrospectively, making the initial diagnosis challenging.


Differential Diagnosis


Differential diagnosis involves distinguishing CHS from other conditions with similar symptoms. Conditions such as cyclic vomiting syndrome (CVS), gastroparesis, and various psychiatric and eating disorders can present similar symptoms.


However, the history of chronic cannabis use, the cyclical nature of symptoms, and the relief provided by hot showers or baths are unique to CHS and can help differentiate it from these other conditions.


Diagnostic Procedures


While the diagnosis of CHS is primarily clinical, certain diagnostic procedures can be used to rule out other conditions. These may include blood tests to check for electrolyte imbalances caused by excessive vomiting, abdominal imaging to rule out structural abnormalities, and gastrointestinal motility studies to exclude conditions like gastroparesis.


In some cases, a trial of cannabis cessation may be recommended. If symptoms resolve with the cessation of cannabis use, this can confirm the diagnosis of CHS.


In conclusion, the diagnosis of CHS requires a thorough clinical evaluation, consideration of the unique features of the syndrome, and the exclusion of other potential causes. This ensures accurate diagnosis and the initiation of appropriate treatment.


Treatment and Management of CHS


 Treatment & Management of CHS


Managing Cannabinoid Hyperemesis Syndrome (CHS) involves immediate treatments to alleviate acute symptoms and long-term strategies to prevent recurrence. The role of healthcare professionals is crucial in providing effective care and support to individuals with CHS.


Immediate Treatments


During an acute episode of CHS, the primary goal is to alleviate severe nausea and vomiting. Often, this involves rehydration, either orally or intravenously, to correct any fluid and electrolyte imbalances caused by excessive vomiting.


Medications to control nausea and vomiting may be used, although they often have limited effectiveness in CHS. Topical capsaicin cream, applied to the abdomen, has been found to relieve symptoms in some cases.


Long-term Management Strategies


The cornerstone of the long-term management of CHS is the cessation of cannabis use. Often, this is the only effective strategy to prevent the recurrence of symptoms. However, given the potential for cannabis dependence, this can be a challenging step for many individuals and may require support from addiction services.


Other long-term strategies include regular follow-ups with healthcare professionals, lifestyle modifications, and mental health support, as individuals with CHS often experience anxiety and depression.


Role of Healthcare Professionals


Healthcare professionals play a crucial role in managing CHS, which includes making an accurate diagnosis, providing immediate treatment during acute episodes, and supporting individuals in their journey to cannabis cessation.


Furthermore, healthcare professionals can provide education about CHS, helping individuals understand their condition and the importance of cannabis cessation. They can also provide referrals to mental health and addiction services as needed.


Prognosis and Complications


Understanding the possible outcomes and potential complications of Cannabinoid Hyperemesis Syndrome (CHS) is crucial for those affected and their loved ones. It helps to set realistic expectations and underscores the importance of effective management strategies.


Possible Outcomes


The prognosis for CHS is generally good with the cessation of cannabis use. Most individuals experience significant relief from symptoms once they stop using cannabis. However, this can be a challenging step, particularly for those dependent on cannabis.


Without cessation of cannabis use, the symptoms of CHS are likely to continue and potentially worsen over time. Recurrent episodes of severe nausea and vomiting can significantly impact an individual's quality of life.


Potential Complications


If not properly managed, CHS can lead to serious complications. Persistent vomiting can result in dehydration, which can lead to kidney failure in severe cases. Additionally, individuals may experience weight loss due to reduced food intake and nutrient loss through vomiting.

Repeated episodes of vomiting can also lead to a condition known as Mallory-Weiss syndrome, where tears in the esophagus can cause bleeding.


History of CHS


Cannabinoid Hyperemesis Syndrome (CHS) is a relatively recent addition to the medical lexicon. It was first described in 2004 by Allen and colleagues in South Australia, who identified a unique set of symptoms in nine patients with a history of chronic cannabis use.


When and How It Was First Discovered


The syndrome was discovered when doctors noticed a pattern of cyclical vomiting and abdominal pain in chronic cannabis users. Interestingly, these patients found relief from hot showers or baths, a feature that became a key diagnostic criterion for CHS.


Evolution of Medical Understanding of the Syndrome


Since its initial description, our understanding of CHS has evolved. It is now recognised as a paradoxical reaction to chronic cannabis use, despite the plant's well-known anti-emetic properties. However, many aspects of CHS, including its exact cause and why only some cannabis users develop the condition, remain areas of ongoing research.


Prevention of CHS


Preventing Cannabinoid Hyperemesis Syndrome (CHS) primarily concerns managing cannabis use. Understanding the measures to reduce risk and the importance of moderation can help prevent this condition's onset.


Measures to Reduce Risk


The most effective measure to prevent CHS is to avoid chronic use of cannabis. For those who use cannabis, particularly for medicinal purposes, it's important to discuss the potential risks with a healthcare professional and consider alternative treatments if possible.


Regular check-ups can also be beneficial, as they allow for early detection of symptoms that could indicate the onset of CHS.


Importance of Moderation in Cannabis Use


For those who choose to use cannabis, moderation is key. High-frequency use and products with high concentrations of THC have been associated with an increased risk of CHS.


It's also crucial to be aware of the early signs of CHS, such as morning nausea and a compulsion to take hot showers, and to seek medical advice if these symptoms occur.


In conclusion, while the use of cannabis may have certain benefits, it's important to be aware of the potential risks, including CHS. Moderation and regular medical check-ups can be crucial in preventing this condition.


The Impact of Legalisation of Cannabis on CHS


The legalisation of cannabis in various parts of the world has significantly impacted the prevalence and understanding of Cannabinoid Hyperemesis Syndrome (CHS).


Trends in CHS Cases with the Legalisation of Cannabis


With the increased accessibility and use of cannabis following its legalisation, reported CHS cases have seen a noticeable rise. This trend suggests a direct correlation between the legal status of cannabis and the prevalence of CHS.


Public Health Implications


The rise in CHS cases presents several public health challenges. Firstly, it underscores the need for increased awareness and understanding of CHS among the public and healthcare professionals, which is crucial for early recognition and treatment of the condition.


Secondly, it highlights the importance of providing clear and accurate information about the potential risks associated with cannabis use, including the risk of CHS.


Finally, it emphasises the need for strategies to manage and support individuals who are dependent on cannabis and are at risk of developing CHS.


Myths and Misconceptions about CHS


 Myths and Misconceptions About CHS


Like many medical conditions, Cannabinoid Hyperemesis Syndrome (CHS) is subject to some myths and misconceptions. These can hinder accurate understanding and effective management of the condition.


Common Misunderstandings about CHS


One common myth is that cannabis, due to its anti-emetic properties, cannot cause a syndrome characterised by severe vomiting. However, while cannabis can help reduce nausea and vomiting in certain contexts, chronic use can paradoxically lead to the severe symptoms seen in CHS.


Another misconception is that CHS can be treated by simply switching the type or strain of cannabis used. However, CHS is associated with chronic use of all forms of cannabis, regardless of the strain or method of consumption.


Clarifications Based on Scientific Evidence


Scientific evidence clearly shows that chronic cannabis use can lead to CHS. The syndrome results from the cumulative effect of cannabinoids in the body, not the specific type or strain of cannabis used.


Furthermore, the only proven treatment for CHS is the cessation of cannabis use. Other treatments, such as hot showers and topical capsaicin cream, can temporarily relieve symptoms but do not address the underlying cause.


Resources and Support for People with CHS


Living with Cannabinoid Hyperemesis Syndrome (CHS) can be challenging, but resources and support are available to help individuals manage this condition.


Support Groups and Other Resources


Online support groups can be a valuable resource for individuals with CHS. These platforms provide a space to share experiences, learn from others, and receive emotional support. Websites such as Facebook and Reddit have active communities dedicated to CHS.


Additionally, local health departments and healthcare providers can provide referrals to mental health services and addiction counselling, which can be beneficial for individuals struggling with cannabis cessation.




In conclusion, Cannabinoid Hyperemesis Syndrome (CHS) is a complex condition associated with chronic cannabis use, characterised by recurrent episodes of severe nausea, vomiting, and abdominal pain. 


Despite the challenges in diagnosis due to its similarity with other conditions, awareness of its unique features, such as symptom relief with hot showers, can aid in early recognition. The cornerstone of treatment and prevention is the cessation of cannabis use, underscoring the importance of moderation and understanding the potential risks associated with chronic cannabis use. With the increasing prevalence of CHS, continued research, public education, and support for affected individuals are crucial in managing this condition.


Can CHS Symptoms Return After Stopping Cannabis Use?

The symptoms of CHS typically resolve with the cessation of cannabis use. However, if an individual resumes cannabis use, the symptoms can return. This is why long-term cessation of cannabis use is the most effective strategy to prevent the recurrence of CHS symptoms.

Are Certain Individuals More Susceptible To Developing CHS Than Others?

While anyone who uses cannabis chronically can develop CHS, some studies suggest that there may be a genetic predisposition, making some individuals more susceptible to the condition. More research is needed to understand this fully.

Can CHS Be Fatal?

While CHS is not typically fatal, if left untreated, the severe dehydration and electrolyte imbalances caused by excessive vomiting can lead to potentially life-threatening complications, such as kidney failure.

Is There A Cure For CHS?

The only known 'cure' for CHS is the cessation of cannabis use. While this may not be easy, especially for habitual users, it is the only way to resolve the symptoms of CHS and prevent their recurrence completely.

Can Other Substances Trigger CHS?

Currently, CHS is specifically linked to the use of cannabis. While other substances can cause similar symptoms, the specific combination of symptoms and their resolution with the cessation of cannabis use is unique to CHS.